Alberto Battaglia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alberto Battaglia has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Fiorenzo Gaita
Department of Medical Sciences, University of Turin, Turin, Italy
3 shared publications - Federico Ferraris
Division of Cardiology, Cardiovascular and Thoracic Department, Città Della Salute e Della Scienza , Corso Bramante 88, 10126, Turin
2 shared publications - Luca Gaido
Divisione di Cardiologia, Dipartimento di Scienze Mediche, A.O.U. Città della Salute e della Scienza, Università degli Studi, Torino
2 shared publications Lucia Garberoglio
Division of Cardiology, University of Turin, Department of Medical Sciences, "Città della Salute e della Scienza" Hospital, Turin, Italy
2 shared publications- Matteo Anselmino
Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy; Department of Medical Sciences, University of Turin, Turin, Italy
2 shared publications Carla Giustetto
Division of Cardiology, University of Turin, Department of Medical Sciences, "Città della Salute e della Scienza" Hospital, Turin, Italy
1 shared publication
Latest Publications
- Open Access
- 23 July 2025
- Published by AccScience Publishing in Brain & Heart
- Vol. 3 (4) , 025040007
Combined atrial fibrillation ablation and left atrial appendage closure: Indications and approaches
Atrial fibrillation (AF) is associated with an increased burden of cardiovascular complications. Early rhythm control has demonstrated promising benefits in this context. Oral anticoagulation has significantly improved overall survival in AF patients by reducing thromboembolic events. However, several comorbidities are linked to an elevated risk of hemorrhagic complications. Left atrial percutaneous appendage closure (LAPAC) is emerging as a promising therapeutic strategy in this subgroup of patients. Interventional cardiologists are increasingly exploring a combined approach involving simultaneous AF ablation and LAPAC to harness the benefits of both procedures and potentially reduce the length of in-hospital stay. According to current literature, the periprocedural safety of combined procedures appears comparable to that of each procedure performed separately, although it is associated with increased hospitalization costs. Notably, the appropriate anticoagulation/antiaggregant therapy regimen following combined procedures remains a subject of ongoing debate. A minimum of 8 weeks of oral anticoagulation is mandatory following AF ablation, irrespective of the patient’s stroke risk or the energy modality used. Conversely, LAPAC should be offered only to patients with contraindications to long-term oral anticoagulation. In the early post-discharge period, no significant differences are observed between combined and isolated procedures. Over long-term follow-up, device thrombosis may occur, with its incidence seemingly unaffected by combined procedures. However, peri-device leaks tend to increase over time in patients undergoing combined procedures, with ridge edema related to radiofrequency delivery considered the primary cause of this phenomenon. New emerging energies (such as pulsed-field ablation) require further evaluation to determine long-term outcomes. According to published position papers, the combined strategy of AF ablation and LAPAC may be a reasonable therapeutic option in selected patients.
- 23 July 2025
- Published by AccScience Publishing in Brain & Heart
- Vol. 3 (4) , 025040007
Open AccessCombined atrial fibrillation ablation and left atrial appendage closure: Indications and approaches
Atrial fibrillation (AF) is associated with an increased burden of cardiovascular complications. Early rhythm control has demonstrated promising benefits in this context. Oral anticoagulation has significantly improved overall survival in AF patients by reducing thromboembolic events. However, several comorbidities are linked to an elevated risk of hemorrhagic complications. Left atrial percutaneous appendage closure (LAPAC) is emerging as a promising therapeutic strategy in this subgroup of patients. Interventional cardiologists are increasingly exploring a combined approach involving simultaneous AF ablation and LAPAC to harness the benefits of both procedures and potentially reduce the length of in-hospital stay. According to current literature, the periprocedural safety of combined procedures appears comparable to that of each procedure performed separately, although it is associated with increased hospitalization costs. Notably, the appropriate anticoagulation/antiaggregant therapy regimen following combined procedures remains a subject of ongoing debate. A minimum of 8 weeks of oral anticoagulation is mandatory following AF ablation, irrespective of the patient’s stroke risk or the energy modality used. Conversely, LAPAC should be offered only to patients with contraindications to long-term oral anticoagulation. In the early post-discharge period, no significant differences are observed between combined and isolated procedures. Over long-term follow-up, device thrombosis may occur, with its incidence seemingly unaffected by combined procedures. However, peri-device leaks tend to increase over time in patients undergoing combined procedures, with ridge edema related to radiofrequency delivery considered the primary cause of this phenomenon. New emerging energies (such as pulsed-field ablation) require further evaluation to determine long-term outcomes. According to published position papers, the combined strategy of AF ablation and LAPAC may be a reasonable therapeutic option in selected patients.
- 7 March 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 66 (11) , 3278-3287
Catheter Treatment of Ventricular Tachycardia: A Reference-Less Pace-Mapping Method to Identify Ablation Targets
Objective: A novel method is developed to identify ablation targets for the catheter treatment of ventricular tachycardia (VT). Methods: The method is based on pacemapping, which is a validated technique to determine the catheter ablation targets. Conventionally, it consists of stimulating the heart ventricle from various sites and comparing the resulting activation pathways to that of a clinical VT, by analysis of surface electrocardiograms (ECG). In this work a novel pace-mapping method is presented, that does not require a reference ECG recording of the VT. A 3D correlation gradient map is reconstructed by semi-automatic analysis of ECG morphological changes within the network of pace-mapping sites. In these maps, abnormal points are identified by high correlation gradient values (i.e. corresponding to slow propagation of the electric influx, as in the core of the reentrant VT circuit). The relation between the conventional and reference-less method is described theoretically and evaluated in a retrospective study including 24 VT ablation procedures. Results: The “reference-less” method was able to identify normal points with a high accuracy (negative predictive value: NPV=97%) and to detect more abnormal points, as predicted by the theory. Correlation gradients computed by the proposed method were significantly higher in ablation zones than in other zones of the ventricle $(p < 10^{-12})$ , indicating excellent prediction of the ablation targets. Significance: The reference-less method might either be used in complement of the conventional method, or to treat patients in whom VT cannot be induced during the intervention.- 7 March 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 66 (11) , 3278-3287
Catheter Treatment of Ventricular Tachycardia: A Reference-Less Pace-Mapping Method to Identify Ablation Targets
Objective: A novel method is developed to identify ablation targets for the catheter treatment of ventricular tachycardia (VT). Methods: The method is based on pacemapping, which is a validated technique to determine the catheter ablation targets. Conventionally, it consists of stimulating the heart ventricle from various sites and comparing the resulting activation pathways to that of a clinical VT, by analysis of surface electrocardiograms (ECG). In this work a novel pace-mapping method is presented, that does not require a reference ECG recording of the VT. A 3D correlation gradient map is reconstructed by semi-automatic analysis of ECG morphological changes within the network of pace-mapping sites. In these maps, abnormal points are identified by high correlation gradient values (i.e. corresponding to slow propagation of the electric influx, as in the core of the reentrant VT circuit). The relation between the conventional and reference-less method is described theoretically and evaluated in a retrospective study including 24 VT ablation procedures. Results: The “reference-less” method was able to identify normal points with a high accuracy (negative predictive value: NPV=97%) and to detect more abnormal points, as predicted by the theory. Correlation gradients computed by the proposed method were significantly higher in ablation zones than in other zones of the ventricle $(p < 10^{-12})$ , indicating excellent prediction of the ablation targets. Significance: The reference-less method might either be used in complement of the conventional method, or to treat patients in whom VT cannot be induced during the intervention.- 28 February 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 236, 328-334
Phenotypic expression of ARVC: How 12 lead ECG can predict left or right ventricle involvement. A familiar case series and a review of literature
- 28 February 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 236, 328-334
Phenotypic expression of ARVC: How 12 lead ECG can predict left or right ventricle involvement. A familiar case series and a review of literature
- 1 January 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 203, 523-524
Left persistent superior vena cava as a source of focal atrial arrhythmias: A late arrhythmia recurrence due to a latent proximal focus
- 1 January 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 203, 523-524
Left persistent superior vena cava as a source of focal atrial arrhythmias: A late arrhythmia recurrence due to a latent proximal focus
- 1 May 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (5) , 777-782
Long-term progression from paroxysmal to permanent atrial fibrillation following transcatheter ablation in a large single-center experience
- 1 May 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (5) , 777-782
Long-term progression from paroxysmal to permanent atrial fibrillation following transcatheter ablation in a large single-center experience